Coronary Stents Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2026


A new market study, titled “Discover Global Coronary Stents Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.



Global Coronary Stents Market

Recently published report on the Coronary Stents Market, found on the Wise Guy Report (WGR) website revealed a great deal about various market dynamics. These dynamics influence the market from a very miniscule level to its holistic standard and can traverse limitations to assist the market achieve an impressive growth rate over the review period of 2019-2026. The report has its core developed by an extensive study supervised by adept analysts. Their sound knowledge and expertise in the field help in unearthing of factors and figures. The report is enriched with a volume-wise and value-wise analysis. To ensure the quality of the report further, market dynamics, various projections, demographic changes, historic details, and others have been included. Several market titans are employing tactical moves to inspire a comprehensive market growth and cement their own market position. This type of analysis provides a better outlook regarding the movement of the market and reveals a lot about the potential of the market. 


Get Free Sample Report at


The new product launch and approval of coronary stents by the regulatory bodies is one of the key factor driving the global coronary stents market. For instance, in February 2017, Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just one stent, which is deployed via a thumbwheel delivery system. In May 2018, B. Braun Interventional Systems Inc. (BIS) in collaboration with NuMED Inc., has announced the U.S. Food and Drug Administration pre-market approval and U.S. commercial launch of an expanded size offering and new indication for the Cheatham-Platinum (CP) Stent portfolio. Moreover, the increasing competitive strategies between companies for increasing their market share for coronary stents is one of the key factor driving the global coronary stents market. For instance, in May 2016, Cordis, Cardinal Health entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health’s interventional vascular business, to sell the coronary stent portfolio of Singapore-based Biosensors International Group, Ltd. to the selected countries in Europe, the Middle East, Africa, Australia, and New Zealand. In June 2018, Cook Medical has partnered with Taewoong Medical to distribute a selection of stents in to the U.S. The new partnership includes the Niti-S Self-Expandable line of metal GI stents. Cook Medical have begun the distribution of Taewoong portfolio on November 1, 2018.

Market Segmentation

By Product

The global coronary stents is segmented based on product type, which include bare-metal stents, drug eluting stents, bioabsorbable stents. Drug eluting stents holds the major market share in 2018 and it is expected to remain dominant over the forecast period, due to the increasing launches and approval of drug eluting stents by the regulatory bodies.

For instance, in March 2017, Medtronic plc have received U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx Drug-Eluting Stent (DES). The Resolute Onyx DES is the first and only DES to feature Core Wire Technology.

In May 2018, Abbott Laboratory have received U.S. Food and Drug Administration (FDA) approval for XIENCE Sierra. XIENCE stents are among the world’s most-used and studied stents and have an exceptional safety record with low rates of complications. Design and technology advances in this generation of XIENCE include features specifically designed for the treatment of complex blockages that now account for up to 70% of cases.

In January 2018, BIOTRONIK have received approval for its Orsiro1 coronary drug-eluting stent (Orsiro DES) from Japanese Ministry of Health.

In September 2018, Terumo Corporation introduced its Ultimaster Tansei drug eluting stent (DES) in Japan market. Ultimaster Tansei DES allows physicians to reach and treat complex anatomies both with radial and femoral access with confidence based on the results of comprehensive clinical program of Ultimaster DES.

By geography

North America is dominating the coronary stents market in 2018, and it is expected to remain dominant over the forecast period, due to rising incidences of heart diseases in this region.

According to National Center for Chronic Disease, around 610,000 people die of heart disease in the United States every year. Moreover, the increasing launces and approval of coronary stents by the regulatory bodies is the key factor driving the North America coronary stents market. For instance, in September 2018, Boston Scientific have received U.S. Food and Drug Administration (FDA) premarket approval for its Eluvia Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD). For a better understanding of the Coronary Stents Market, a better grip over the macroeconomic and microeconomic factors are needed as they are impacting the market towards progress. These factors can ensure a swift helming of the market through rough patches of economic crisis and help in averting plummeting results. With real-time data, the report captures the essence of the market and provides a close reading of demographic changes. This would assist market players in assessing growth opportunities and optimally use resources provided by growth pockets.

However, the fragmented Coronary Stents Market has several new entrants that are giving tough competition to the established names. As a result, the Coronary Stents Market is opening up and is becoming active with new merger, acquisition, product launch, collaboration, innovation, and other methods. At the same time, these tactical moves depend a lot on their geographical location as the demography facilitates moves. A close inspection of these regions has been included as well to simplify demographic understanding.


Get Detailed Report at


Major Key Points of Global Coronary Stents Market

  • Key companies to watch 
  • Emerging Companies 
  • APPENDIX     

Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India